In particular, we predicted that CD24 is the target of let-7a and miR-98 with PAOM scores 48.2 and 12.0, respectively, in breast cancer,19 which was previously verified by Kaipparettu et al.19 Further studies will be necessary to verify those findings. The gene discussed is CD24; the disease is breast cancer.